Results 261 to 270 of about 9,110,443 (315)

Meningococcal Disease

New England Journal of Medicine, 2001
Item does not contain ...
N E, Rosenstein, B A, Perkins, D S, Stephens, T, Popovic, J M, Hughes   +4 more
openaire   +4 more sources

Meningococcal disease: The advances and challenges of meningococcal disease prevention

Human Vaccines, 2011
Vaccination as a means to prevent meningococcal disease caused by Neisseria meningitidis is critical given the abrupt onset and rapid progression of this disease. Five serogroups--A, B, C, W-135, and Y--are responsible for the majority of cases. In developed countries, infants have the greatest risk of disease, with a smaller secondary peak observed in
Ram Yogev, Tina Tan
openaire   +3 more sources

Meningococcal carriage, meningococcal disease and vaccination

Journal of Infection, 1988
Group A meningococcal carriage rates were determined 6 months before and 6 and 18 months after a mass vaccination campaign with a combined group A and group C meningococcal polysaccharide vaccine in a rural area of The Gambia. During the first pre-vaccination survey, performed during an outbreak of meningococcal disease, the carriage rate was high (16%)
R.A. Wall, Musa Hassan-King, Brian Greenwood   +2 more
openaire   +3 more sources

Chronic meningococcal disease

Medical Journal of Australia, 1990
Chronic meningococcal septicaemia is an unusual and infrequently recognised presentation of disease caused by Neisseria meningitidis. Clinical features are immunologically mediated and include fever, rash and arthritis, which may mimic cutaneous vasculitis or reactive gonococcal arthritis. Diagnosis is difficult to confirm as blood cultures commonly do
Jennens Id, O'Reilley M, Yung Ap
openaire   +3 more sources

First real world evidence of meningococcal group B vaccine, 4CMenB, protection against meningococcal group W disease; prospective enhanced national surveillance, England.

Clinical Infectious Diseases, 2020
BACKGROUND 4CMenB is a protein-based meningococcal group B vaccine but the vaccine antigens may also be present on non-group B meningococci. In September 2015, the UK implemented 4CMenB into the national infant immunisation programme, alongside an ...
S. Ladhani, H. Campbell, N. Andrews, S. Parikh, Joanne White, M. Edelstein, S. Clark, J. Lucidarme, R. Borrow, M. Ramsay   +9 more
semanticscholar   +1 more source

Meningococcal disease

Nursing Standard, 1998
This article discusses meningococcal disease and outlines the role of the nurse in treating patients who may suffer from meningitis, one of the illnesses caused by meningococcal disease. It goes on to discuss how nurses can support the relatives of these patients.
openaire   +2 more sources

Meningococcal disease in Africa

Annals of Tropical Medicine And Parasitology, 1997
Neisseria meningitidis (the meningococcus) is responsible for endemic and meningococcal disease in Africa. Meningococci are placed into 12 serogroups based on their capsular polysaccharide antigens. Group-B meningococci are responsible for sporadic endemic disease.
Luis E. Cuevas, C. A. Hart
openaire   +3 more sources

Meningococcal disease and travel

International Journal of Antimicrobial Agents, 2003
Meningococcal disease continues to be a worldwide problem. This review examines the impact meningococcal disease has on international travel and vice versa the impact international travel has on the intercontinental spread of meningococci. The risk of meningococcal disease to the endemic population differs from that of travellers.
Ziad A. Memish, Annelies Wilder-Smith
openaire   +3 more sources

Influenza A and meningococcal disease

The Lancet, 1991
There are several anecdotal accounts of the association between outbreaks of influenza and meningococcal disease. The exceptional increase in the number of cases of meningococcal infection 2 weeks after an influenza A outbreak in England and Wales during November and December, 1989, provided an opportunity to investigate the relation between the two ...
J. M. Stuart, D. M. Jones, Kaczmarski Eb, K. Cartwright, A. J. Smith, S.R. Palmer   +5 more
openaire   +6 more sources

CD46 in Meningococcal Disease

Science, 2003
The human-specific bacterial pathogen Neisseria meningitidis is a major cause of sepsis and/or meningitis. The pili of N. meningitidis interact with CD46, a human cell-surface protein involved in regulation of complement activation.
Peter Bergman, Helena Källström, Anne Rytkönen, Barbara Albiger, Linda Johansson, Roberto Cattaneo, Ann-Beth Jonsson, Tomas Hökfelt, Birgitta Agerberth   +8 more
openaire   +2 more sources